share_log

JP Morgan Downgrades Treace Medical Concepts to Neutral, Lowers Price Target to $8

JP Morgan Downgrades Treace Medical Concepts to Neutral, Lowers Price Target to $8

摩根大通將Treace Medical Concepts的評級下調至中性,將目標股價下調至8美元
Benzinga ·  05/08 08:21

JP Morgan analyst Robbie Marcus downgrades Treace Medical Concepts (NASDAQ:TMCI) from Overweight to Neutral and lowers the price target from $15 to $8.

摩根大通分析師羅比·馬庫斯將Treace Medical Concepts(納斯達克股票代碼:TMCI)的評級從增持下調至中性,並將目標股價從15美元下調至8美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論